
Recent Articles
How to Time Palantir Stock Entry Without Guesswork
By
Nicolas Chahine, InvestorPlace Contributor
PLTR stock is worth owning for the long term but it is best to pick favorable entry points to avoid obvious potential pitfalls.
ViacomCBS Stock Is in Shambles but That’s What Attractive About it
By
Nicolas Chahine, InvestorPlace Contributor
VIAC stock is definitely a broken stock but far from a broken company. The fundamentals will lend support, so it's an entry opportunity.
XPeng Stock Has Support from the Fundamentals and Technicals
By
Nicolas Chahine, InvestorPlace Contributor
XPEV stock price action does not match the quality of the company results yet. It's likely that investors will realize that later this year.
3 Easy Ways to Bring Balance to a Bullish Portfolio
By
Nicolas Chahine, InvestorPlace Contributor
Finding stocks to buy during bullish markets is easy. However it is time to bring balance into portfolios during historically bad seasons.
This Is Not an Obvious Entry Point into Exxon Stock
By
Nicolas Chahine, InvestorPlace Contributor
The time to be bullish on XOM stock has passed. Coming into the pandemic crash levels, the opportunity becomes less attractive than last year.
DoorDash Stock Is Due for Better Days Going Into the Summer
By
Nicolas Chahine, InvestorPlace Contributor
DASH stock has had a tough time so far but there could be relief coming. The consolidation could turn into an swing trade opportunity.
Bionano Genomics Stock Is Too Wild for Its Own Good
By
Nicolas Chahine, InvestorPlace Contributor
BNGO stock has seen too much action without fundamental justification. It makes a better speculative bet than an investment.
3 Momentum Stocks Ready to Catch Fire Into the Summer
By
Nicolas Chahine, InvestorPlace Contributor
Momentum stocks present a challenge to most investors. They move so fast that they rarely leave easy entry points, but they are worth chasing.
We Love Sparky, So We Should Also Like Chewy Stock
By
Nicolas Chahine, InvestorPlace Contributor
CHWY stock is headed higher over time. Management is executing well and the fundamentals are improving fast. Time will handle the rest.
Zomedica Stock Is Not for the Casual Investor
By
Nicolas Chahine, InvestorPlace Contributor
The interest in ZOM stock is purely speculative. There is absolutely zero reason to chase it stemming from the current fundamentals.

Join Louis Navellier’s Market 360 — FREE!
Get Louis Navellier’s take on the news and events impacting the market, plus his top stock picks.